No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Oculis Holding (OCS)
Processa Pharmaceuticals | 10-Q: Quarterly report
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next gen
Express News | Processa Pharmaceuticals Names DR. Steven Cha Senior Vice President of Clinical Research
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
No Data